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Abstract 
The purpose of this study was to examine the effects of beta-blockers on memory in 
patients at the Ann Arbor Veterans Affairs Hospital. Tests scores from a standard 
neuropsychological screening battery at the Ann Arbor Veterans Affairs Hospital, were 
compared between patients taking beta-blockers versus patients not taking beta-blockers, 
controlling for age and level of education. There was no statistical significance between 
the two groups. Results suggest that in non-demented, non-delirious older adult inpatients 
in an extended rehabilitation setting, regularly prescribed doses of beta-blockers do not 
adversely affect memory. More detailed analysis including measurable doses of beta-
blockers should be conducted in the future.  
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Effects of Beta-blockers on Memory in Veterans at the Ann Arbor Veterans Affairs 
Hospital 
Time trends have shown that the use of beta-blockers in older adults have been 
increasing annually (Smith, Chan, Jeannie, Rea, Wiggins, Gottdiener, Lumley, & Pasty, 
2004). On November 14, 2005, the New York Times reported that beta-blockers 
(especially atenolol) were the fourth most-prescribed drug in the United States, with 44 
million prescriptions yearly (Berenson, 2005). Apart from its ability to reduce mortality, 
the quality of life of patients on beta-blockers should also be addressed. Standard 
indicators of the quality of life include wealth and employment, built environment, 
physical and mental health, education, recreation and leisure time, and social belonging 
(Johnston, Gregory, Watts, Whatmore, & Pratt, 2009). In this study, we were interested in 
the impact of beta-blockers and memory- an important part of mental health.  
 Previous research on beta-blockers on cognition has yielded 
contradictory conclusions - many conclude that beta-blockers have no effects on 
cognition (Deary, Capewell, Hajducka, & Muir, 1991; Dimsdale, Newton, & Joist, 1989; 
Powell, Pickering, Wyke, & Goggin, 1993; Pérez-Stable, Halliday, Gardiner, Baron, 
Hauck, Acree M. & Coates, 2000), some conclude that beta-blockers have negative 
effects on cognition (Hartley, Ungapen, Davie, & Spencer, 1983; Lichter, Richardson, & 
Wyke, 1986; Richardson, & Wyke, 1988; Solomon, Hotchkiss, Saravay, Bayer, Ramsey, 
& Blum,1983), and some studies have even found positive effects on memory (Dimsdale, 
Newton, & Joist, 1991; Quervain, 2007).  Hence, there is a need to reexamine the effects 
of beta-blockers on memory. The present paper describes a study of beta-blockers 
specifically on memory. 
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 Although there is a large literature, this literature is inconsistent for two reasons. 
Firstly, almost half of these articles are based on small sample sizes, i.e less than 20 
subjects. Secondly, previous tests have been too broad – testing all aspects of brain 
functioning. Neuropsychiatric testing measures a wide array of mental abilities and beta-
blockers do not seem to affect all the different aspects of brain functioning; memory, 
however, appears to be specifically affected (Dimsdale et al., 1989). This study tries to 
overcome the unreliability by using a sample size of 469 patients and focusing on 
memory aspects of neuropsychological tests.  
Biochemistry of Beta-blockers 
Beta-blockers, also known as beta-adrenergic blocking agents, are medications 
that reduce blood pressure. Examples of beta-blockers include Acebutolol (Sectral), 
Atenolol (Tenormin), Bisoprolol (Zebeta), Carvedilol (Coreg), Metoprolol (Lopressor, 
Toprol XL), Nadolol (Corgard), Nebivolol (Bystolic) and Propranolol (Inderal LA) 
(Mayo clinic staff, 2008).  
Beta-blockers differ by cardioselectivity, lipid solubility, and the presence or 
absence of intrinsic (agonist) sympathomimetric activity (ISA). As lipid solubility 
increases, the liver metabolizes more of the drug, more of the drug enters the brain, and 
its duration of action is shorter. As lipid solubility decreases, the drug is eliminated by 
renal excretion, less of the drug enters the brain, and its duration of action is longer. The 
most lipid-soluble drugs (lipophilic) - propranolol, penbutolol, and carvedilol are 
preferred in the presence of renal disease. Intermediate lipid-soluble drugs are 
metoprolol, prondolol and timolol. The least lipid-soluble drugs (lipophobic) atenolol, 
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betaxolol, carteolol, celiprolol, esmolol, sotalol and nadolol are preferred in the presence 
of liver disease (Habermann, 2008). 
Atenolol a beta-1 (ß-1) cardioselective adrenoreceptor blocking substance, 
actively restricts certain hormones and neurotransmitters, thereby controlling the rate and 
force of contraction, consequently reducing blood pressure. The human body contains 
receptors that act to receive chemicals released from glands or nerves. The adrenal gland 
releases adrenaline (epinephrine) and in the sympathetic flight or fight response, the 
nerves secretes noradrenaline (norepinephrine). The hormone (adrenaline) facilitates the 
conversion of ATP to cAMP. The complimentary receptors for these chemicals are alpha 
and beta-adrenergic. Sympathetic activity is communicated to tissues through involuntary 
(autonomic) nerve impulses and through the blood.  
The endocrine system responds to beta-adrenergic receptor stimulation by 
increasing blood sugar levels, inducing a faster heart rate and producing stronger heart 
contractions all by means of secreting adrenaline. This results in an increase of blood 
pressure. Atenolol blocks the receptor targets on heart muscle cells and prevents 
epinephrine and norepinephrine from stimulating the cardiovascular system. The heart 
beats more slowly and with less force, thereby reducing blood pressure and minimizing 
cardiovascular stress. The beta-blockers induce a nitrate pathway, which give rise to 
vasodilatation (dilation of arteriolar resistance vessels), thus helping to reduce symptoms 
of arrhythmias and minimize cardiovascular stress (Encarta, 2003).  
 Although beta-blockers have been associated with cognitive effects, hypertension 
itself may also have cognitive effects. Hypertension increases the risk of cerebro-vascular 
diseases such as stroke and may also have a role in the development of vascular cognitive 
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impairment and vascular dementia (Rigaud, Hanon, Bouchacourt, & Forette, 2000; 
Prince, 1997). Kaplan, (2001) has shown that the brain benefits from lowering 
abnormally elevated blood pressure and that reduction of hypertension protects the brain 
from stroke and cognitive impairment in later life. Neuropathological and 
neuropsychological investigations have shown that hypertensive patients more often have 
areas of white matter hyperintensity and ventricular enlargement compared to 
normotensive individuals (Harrington, Saxby, McKeith, Wesnes, Ford, 2000).  
 It is documented that there is an association between hypertension and reduced 
cerebral blood flow and vascular dementia. Longitudinal studies have also suggested that 
hypertension in midlife is associated with cognitive impairment later in life (Amenta, 
Mignini, Rabbia, Tomassoni, &Veglio, 2002). There is some understanding of the 
biological pathways of beta-blockers on hypertension. Although the exact biological 
pathways of the effect of beta-blockers on cognition have not been found, it is clear that 
there is an association between beta-blockers and cognition. 
Previous findings on the role of beta-blockers in cognition 
Previous research on beta-blockers of cognition has yielded conflicting 
conclusions. Hence, there is a need to critically access and review some of these studies. 
No effects on cognition 
Dimsdale et al. (1989) conducted a review of fifty-five studies of cognitive side 
effects of beta-blockers. They found that
 
across all beta-blockers and all cognitive 
domains, the drugs
 
led to improved functioning in 16% of observations and worsened
 
functioning in 17%, with no significant effect in the rest. They also established from 
previous studies that memory, learning, and abstraction (quality of dealing with ideas 
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rather than events) was studied less frequently.
 
The perceptual motor cognitive domain 
was the most widely studied
 
and was frequently affected by beta-blockers. However, 
there was no consistent
 
evidence of a trend for lipophilic beta-blockers, which as 
discussed earlier entered the brain and should affect cognition, to affect cognition more 
than lipophobic beta-blockers (less lipid-soluble drugs). The
 
drugs also seem to increase 
sedation; however, in these studies
 
there was no evidence for a differential effect across 
lipophilic
 
vs lipophobic beta-blockers. 
 Likewise, Deary et al. (1991) conducted a double blind, double-dummy, 
randomized cross-over trial which compared the effects of atenolol (50 or 100 mg once 
daily) and captopril (25 or 50 mg twice daily), each taken for 6 weeks and their effects on 
memory, information processing ability, mood states and trait anxiety. Eighteen patients 
with mild to moderately severe hypertension were included. Patients undertook practice 
on the psychological test battery prior to the treatment phases of the study in order to 
minimize practice effects. There were no significant differences between the treatments, 
on any of the measures of memory or information processing. Patients reported feeling 
less anxious during treatment with atenolol. There were no differences between the drugs 
in their cognitive effects.  However, reduction of anxiety by atenolol may mask possible 
effects of beta-blockers. A study needs to be done to compare patients on atenolol and no 
atenolol (control) which similar levels of anxiety and their effects on memory. 
 Similarly, in an investigation of the differential effects of three different anti-
hypertensive medications (cilazapril, atenolol, nifedipine) on cognitive function, Powell 
et al. (1993) did not find a significant effect from any of them. A sub-group of patients 
participating in a large clinical trial of these three drugs, was randomly allocated between 
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the three drug conditions and received cognitive assessment at two points before the 
commencement of treatment and then after 12 and 24 weeks of treatment. Seventy-six 
patients began treatment, and 55 completed the full course. Tests of learning and memory 
(explicit and incidental) were specially designed for the study, with a different but 
comparable version administered on each assessment occasion (to reduce practice 
effects), in a fixed order. No significant differences between drug groups were found in 
any index of learning or memory, at any testing occasion. 
 The most recent study, a placebo-controlled trial among 313 men and women, 22 to 
59 years of age, who had untreated diastolic hypertension (90 to 104mmHg) found that 
treatment of hypertension with propranolol had limited adverse effects on tests of 
cognitive function that were of questionable clinical relevance. Thirteen tests of cognitive 
function (7 tests measured memory or learning verbal information) were assessed at 
baseline, 3 months and 12 months. At baseline, there were differences between the 
groups in two tests of cognitive function – the continuous performance task error of 
commission and the Tuesday list from the California Verbal Learning Tests. However, 
neither of these differences were large. There were no statistically significant or clinically 
important differences in any of the other 12 tests of cognitive function (Pérez-Stable et 
al., 2000). 
Negative effect of beta-blockers  
 Propranolol 40 mg was compared with a matched placebo tablet in its effect on the 
performance of anxious and non-anxious human volunteers in a study by Hartley et al., 
(1983). Subjects were prompted, by being given the first letter, to recall both difficult and 
easy words, drawn from selected verbal categories; propranolol impaired recall of 
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difficult items in the memory of anxious subjects, compared to placebo.  There was also a 
three-way interaction between drug, anxiety and dominance. Results were interpreted as 
showing a central as well as peripheral role for propranolol in blocking adrenergic 
receptors' activity in anxiety.  
Similarly, Solomon et al. (1983) found that verbal memory impairment was 
present in hypertensive and non-hypertensive patients taking methyldopa or propranolol 
hydrochloride, while hypertensive patients receiving only a diuretic did not show this 
deficit. Visual memory impairment was not seen in any of the groups tested. The majority 
of the subjects were unaware of their memory deficit, even when test results clearly 
revealed impairment. An earlier pilot study of 12 hypertensive patients receiving 
methyldopa or propranolol used a broad range of cognitive tests and also demonstrated 
impairment in verbal memory only, while other cognitive measures remained relatively 
unaffected. 
Impaired memory associated with beta-blockers was also found in another 
experiment that compared the effects of different anti-hypertensive drugs. Memory 
function was assessed in a group of patients treated with either a beta-blocker (atenolol) 
or an angiotensin-converting enzyme inhibitor (enalapril) in a randomized, observer-blind 
study in moderate essential hypertension. The patients were assessed, on placebo and 
after 16 weeks of treatment on active therapy, by use of a series of 4 memory function 
tests related to everyday life. In the hypertension study group, 13 received atenolol and 
12 received enalapril. In the atenolol group memory performance scores were 
consistently lower than in the placebo phase in 9 of 28 estimates of memory function. In 
the enalapril group there were no significant changes. The study indicated that atenolol 
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might produce mild memory impairment, whereas enalapril had no measurable effect on 
memory function (Richardson et al., 1988). 
 Lichter et al. (1986) conducted a randomized single-blind study to compare the 
performance on memory tests requiring recall of information relevant to everyday life of 
two groups of hypertensive patients. In the hypertension study group, 13 received 
atenolol and 12 received enalapril. In the atenolol group memory performance scores 
were consistently lower than in the placebo phase in 9 of 28 estimates of memory 
function: trials 1 & 6 (shopping list test), trial 4 (Logos), trials 2-7 (Telephone Extension 
numbers). In the enalapril group there were no significant changes. The study indicated 
that atenolol might produce mild memory impairment, whereas enalapril had no 
measurable effect on memory function. 
Improvement in memory 
 In contrast, Dimsdale et al. (1991) found a significant improvement in memory. He 
conducted a double-blind study on the effects of non-lipophilic beta-blocker (atenolol) 
and lipophilic beta-blocker (metoprolol) on neuropsychological functioning, mood, 
sedation and sleep. Thirty-five hypertensive patients had their dosage of antihypertensive 
medication slowly reduced and a under went a 3-wk placebo washout. They were the 
randomized to receive double-bind either atenolol or metoprolol for 4 weeks. 
Neuropsychological testing was carried out twice, at the end of placebo period and after 4 
wk of active treatment. Drug treatment with either drug was associated with a small but 
significant improvement in functioning on the Trails B, Digit Symbol substitution, 
Wechsler delayed memory and PSAT tasks. 
 Also in a double blind, placebo-controlled study, 42 healthy volunteers were 
EFFECT OF BETA-BLOCKERS ON MEMORY 11 
presented a set of words with variable emotionality and asked to learn them for recall. A 
day later, cortisone (25 mg), propranolol (40 mg), or both drugs were administered 1 hour 
before the test. Cortisone selectively impaired the recall of emotionally arousing words 
by 42%. Propranolol alone did not affect recall of either emotional or neutral words. A 
pharmacological blockade of B-adrenceptors prevents glucocorticoid-induced memory 
retrieval deficits in human subjects (Quervain, 2007). 
 Most of these studies have a sample size of less than a hundred with 313 being the 
largest. In each study, there were too many tests administered and hence too broad – 
testing all aspects of brain functioning, leaving them vulnerable to produced spurious 
results. The present study focuses only on measures of memory – using the Mini-mental 
state examination (MMSE), Rey Fifteen-Item Test of Memory and Hopkins verbal 
learning test (HVLT). Hence we aimed to overcome the unreliability of small sample size 
by using a sample size of 469 patients and limiting cognitive measures to memory aspects 
of neuropsychological tests.  
Methods 
All patients admitted to the Ann Arbor Veterans Affairs Hospital (AAVAH) 
Community Living Center (CLC) undergo a standard battery of cognitive tests. This is to 
provide quantification of cognitive functioning, and is helpful in treatment planning, 
identifying deficits and suggesting methods of compensation, and tracking changes in 
function over time. 
A search was conducted on a database containing demographics, medical history, 
prescription and cognitive test data of patients who were evaluated in the CLC from 
January 2000 to 2009. The database was a compilation of self-collected data and a 
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preexisting database of 639 patients who were evaluated in the CLC from January 2000 
to January 2007. Together, the data compiled from January 2000 to August 2009 
consisted of 781 cases, before initial selection. 
Participants 
Participants were selected based on scores on certain subtests from the cognitive 
screen. Participants were excluded based on the following criteria: failing scores of 
measures of effort (Rey Fifteen Item Test of Memory [FIT] <9), failing scores on a brief 
mental screen (MMSE <18), and probable delirium (Memorial Delirium Assessment 
Scale [MDAS] >7). In the battery of measures used in the CLC, the HVLT-R (Hopkins 
Verbal Learning Test – Revised) is an effective of test memory, initial learning, learning 
with repetition, learning strategy, recall and recognition. Hence, this was our primary test 
of memory in this study.  
After excluding patients who do not meet the mentioned requirements, 469 
participants were included in the study. Of 469 participants, 447 were male (95.3%) and 
22 were female (4.7%). Ages of participants ranged from 22 to 100, (M=62.75, SD = 
11.51). Two hundred and thirty three were in the control group (Mean age = 60.61) and 
two hundred and thirty six people were in the medicated group (Mean age = 64.87). 
There was a significant difference in age (p <0.0001) and education (p=0.017) between 
the two groups, with the control group being older and less educated (Table 1). 
Cognitive measures 
The battery of measures in the community living center includes the mental state 
examination (MMSE), Wide range achievement test (WRAT4), Digit span, Rey Fifteen-
Item Test of Memory, judgment, memorial delirium scale (MDS), trails A and B, Frontal 
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assessment battery (FAB), Hopkins verbal learning test (HVLT), Controlled oral word 
association test (COWAT), Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition (DSM-IV), Brief Visuospatial Memory Test-Revised (BVMT-R) – of 
which we used Mini-mental state examination (MMSE), Rey Fifteen-Item Test of 
Memory, Hopkins verbal learning test (HVLT) and memorial delirium scale (MDS).  
Mini Mental State Examination. It is widely used and a convenient test of 
cognition (Folstein & McHugh, 1975), because with limited resources and time, it gives a 
rough estimate of cognitive ability. Abilities measured include orientation, language 
(repetition, comprehension, reading, writing and naming), concentration (serial 
subtractions, backward spelling and following a three stage command), memory (three 
word registration, three word recall (MMSE-RT)) and visual processing and construction 
(copying a simple geometric figure).  The total score is used as a screening measure of 
general mental status. The MMSE has proven to have good reliability and validity 
(Folstein et al., 1975).  
An impaired score (total score less than 24) is usually used as an indicator of 
cognitive impairment (Tombaugh, McIntyre, & Nancy, 1992). In our study, we excluded 
participants with a score of 17 and below. Individuals with possible impairment (score 
between 18 and 23) were included because excluding them could also exclude those 
patients most affected by beta-blockers. Total MMSE score was used for participant 
selection. It was also used to compare the two groups for a measure of general cognitive 
ability and not memory itself. MMSE-RT was used as a measure of memory.  
Memorial Delirium Assessment Scale. The MDAS (Breitbart, Rosenfeld, Roth, 
Smith, Cohen, & Passik, 1997) is a post screening measure of delirium. The interviewer 
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rates the patient on a scale from 0: none to 3:s evere for each category. Questions include 
assessments of impairment in consciousness, disorientation, perceptions, delusions, 
psychomotor activity, and sleep-wake cycles. It has been shown to be reliable and valid 
(Breitbart et al., 1997; Lezak, 1995). The patients who received a failing score (>7) on 
this measure were excluded because scores more than a 7 are highly indicative of 
delirium.  
Rey Fifteen-Item Test of Memory. The FIT (Rey, 1964) is designed to assess 
effort and exaggeration or feigning of memory complaints (Boone, Salazar, Lu, Warner-
Chacon, & Razani, 2002). Patients are given 10 seconds to study a sheet of paper with 15 
items on it. Unknown to the patients, the items are related and can be easily categorized 
for easier memorization. The items include shapes, counting numerals and roman 
numerals. After ten seconds is over, subjects are asked to redraw the items that they saw 
on the paper. The overall task is very simple and even individuals who have sustained 
severe brain damage are able to pass the test. Research shows that if a patient scores 9 or 
below, the may be considered as putting forth poor effort (Goldberg & Miller, 1986; 
Reznek, 2005). Patients who scored less than 9 on this measure were excluded as this 
usually means that the results of the battery are not a true reflection of their mental 
abilities. Scores for this measure were also used only for participant selection and not for 
comparisons between groups. The FIT has proven to have high validity and reliability as 
a measure of effort (Goldberg & Miller, 1986; Taylor, Kruetzer & West, 2003).  
Hopkins Verbal Learning Test. Tests such as the HVLT (Hopkins Verbal 
Learning Test – Revised) are effective in testing memory, initial learning, learning with 
repetition, learning strategy, recall and recognition (Brandt, 1991). A word list with 
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twelve words is read to the patient and the patient is asked to recall as many words as he 
or she can remember from the list, in any order. This process is repeated three times. The 
twelve words on the wordlist are related and can be categorized into three groups. 
However, the patient is not told that the words are related prior to testing.  
After a 20-minute delay, a delay trial (HVLT4) is conducted - the patient is asked 
to recall as many of the words as he or she can from the list.  Then, a yes/no format 
recognition test is administered, during which the original lists of words are presented 
amongst semantically related and semantically unrelated distracter words. HVLT trails 1 
to 3 measures immediate memory and HVLT trail 4 and HVLT recognition trail 
measures delayed memory. All in all, the HVLT has shown to have good reliability and 
validity (Benedict et al., 1998). 
Statistical Analysis 
Bivariate correlations were computed to determine if there was potential 
correlation between demographic variables and outcomes. Data was analyzed using 
multiple linear regressions to determine the effects of beta-blockers on each of the 
following outcomes. MMSE total score (19-30), MMSE Three-word Recall (0-3), HVLT 
trials 1-3 (0-36), HVLT trial 4 (0-12). All analysis controlled for age, gender, and years 
of education. Beta-blockers was entered as a dichotomous variable. We predicted that 
patients who received beta-blocker medication would have significantly lower outcomes 
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Results 
Preliminary analysis 
 The mean MMSE score for patients on beta-blockers was 26.95 (SD= 2.25) and 
for patients not on beta-blockers was 26.99 (SD =2.38). The mean HVLT trails 1 to 3 
score for patients on beta-blockers was 17.57 (SD = 5.38) and for patients not on beta-
blockers was 18.27 (SD=5.14). Please refer to Table 2 for details. Significant correlation 
was found between age and test scores, education and test scores.  See table 3 for more 
details.  
We found no interaction between age and beta-blocker (p=0.5844), and education 
and beta-blocker (p=0.1207), when predicting MMSE total scores. We also found no 
interaction between age and beta-blocker (p=0.7447), and education and beta-blocker 
(p=0.5864), when predicting HVLT Trail 1 to 3 scores. Hence we did not include the 
interaction term in our multi linear regression models.  
Results from multi linear regression  
 There was no statistically significant difference in test scores for patients who 
were on beta-blockers versus patients who do not take beta-blockers, controlling for age 
and education level. There were some small differences in test scores between patients 
who take beta-blockers versus patients who do not take beta-blockers. Patients who took 
beta-blockers had 0.209 higher HVLT trail 1 to 3 scores (p=0.650), 0.140 higher HVLT 
trail 4 scores (p=0.624) and 0.145 higher HVLT recognition scores (p=0.522) compared 
to patients who did not take beta-blockers. The groups also did not differ on MMSE 
scores. However none of these differences were statistically significant. 
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Discussion 
There was no statistical significance between the individuals taking beta-blockers 
and individuals not taking beta-blockers on measures of general mental status and 
memory. These results differ from previous findings of negative effects (Hartley et al., 
1983; Lichter et al., 1986; Richardson et al., 1988; Solomon et al., 1983) and positive 
effects (Dimsdale et al., 1991; Quervain, 2007) of beta-blockers. Our results suggest that 
in non-demented, non-delirious older adult inpatients in an extended rehabilitation 
setting, regularly prescribed doses of beta-blockers do not adversely affect memory. 
There are many possible reasons as to why our results are different from previous 
findings. 
 Firstly, it may be possible that the patients have developed tolerance to beta- 
blockers over their course of medication. There have yet to be any data published that 
purposefully studied if patients developed tolerance and its effects on memory. However, 
studies have shown that there was little changes in blood pressure and heart rate as beta-
blocker dosages increased from 100% to 125% and 150% of the original dosage (Krum,  
Ninio, MacDonald, 2000; Tandon, McAlister, Tsuyuki, Hervas-Malo, Dupuit, Ezekowitz, 
Cujec & Armstrong, 2004).  This meant that patient’s body and brain’s response to beta-
blockers may have diminished and this phenomenon meant that there would not be any 
significant effects on memory.  
 We were not able to ascertain how long the patients have been taking beta-blockers. 
Hence, we were not able to find out if they had developed tolerance and whether this 
tolerance affected their memory. Hence, a future study can be done to compare the 
memory of patients who have taken beta-blockers for a long time versus patients who 
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have just started taking beta-blockers.  
 It may also be possible that the majority of the patients in our study were taking 
lipophobic drugs. Lipophobic drugs have low lipid solubility and are eliminated by renal 
excretion. Hence, less of the drug enters the brain and has less detrimental effects on the 
brain. Although Dimsdale et al. (1989) found no consistent
 
evidence of a trend for 
lipophilic drugs to affect cognition more than lipophobic drugs, more studies can be done 
to compare cognitive effects between patients on lipophilic drugs and lipophobic drugs, 
with emphasis on memory.  
 There may also be a difference between older and newer beta-blockers on memory. 
There exists a wide range of pharmacological routes to the treatment of essential 
hypertension. The older agents, including diuretics and B-adrenoceptor blockers, are very 
effective in reducing blood pressure but they also cause many adverse effects, such as 
unwanted metabolic changes (Ames, 1986; Kaplan, 1986; Knochil, 1984; Murphy et al., 
1982). The metabolic changes are dose-dependent and are difficult to repeat after 1 year. 
Newer drugs including calcium antagonists and angiotensin-converting enzyme (ACE) 
inhibitors, are no more effective than the older drugs but there is some evidence that they 
lack the adverse metabolic effects (Hedner et al., 1987; Pollare et al., 1989). It is possible 
that memory impairments described in other literature occur in patients taking only the 
older class of anti-hypertensive medication and our patients took newer classes of beta-
blockers. Pharmaceutical companies may have made adjustments to the newer beta-
blockers. Hence, they have no effect on cognition and specifically memory.  
Beta-blockers as a class have many undesirable effects including drowsiness, 
lethargy, sleep disturbance, visual hallucinations, depression, blurring of vision and 
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dreams/nightmares that may affect their attention during cognitive tests. They also have 
pulmonary side effects such as increased airway resistance in asthmatics, and peripheral 
vascular side effects such as cold extremities, Raynaud’s phenomenon, erectile, and 
orgasmic dysfunction (Messerli et al., 2002). Hence, in other studies, it might be 
drowsiness and lethargy that cause effects on memory and not beta-blockers per se.  
However, in another study, 167 men treated with beta-blockers showed a 
proportionally lower prevalence of sleep complaints (Gislason, & Almqvist, 1987). 
Hence, patients on beta-blockers might not have been affected by sleep enough to affect 
their test scores. This supported our findings that there is no significant difference in test 
scores between patients on beta-blockers and patients not on beta-blockers. Given the 
design of our study, it is difficult to know whether memory functioning was confounded 
by lethargy or sleep disturbances.  
There is even some data suggesting that untreated hypertension is itself associated 
with cognitive effects (Reitz et al., 2007). Hence, it might just be hypertension that is 
affecting tests score on memory rather than the effects of beta-blockers. A study to 
compare memory between hypertensive patients on beta-blockers versus hypertensive 
patients that are not treated has to be conducted. 
 We realize that by excluding individuals based on the MDAS for delirium we 
may have excluded some individuals showing cognitive impairment due to beta-blockers. 
This might be possible because there was a case report of acute delirium induced by 
metoprolol (Fisher et al., 2002) and one other report of metoprolol-induced delirium 
perpetuated by propaferone (Ahmad, 1991). 
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Drug interactions may have an effect on test results. Many of the older adult 
inpatients in the community living center (an extended rehabilitation setting) in the 
Veterans Affairs hospital have other medical problems and many are on several different 
types of medications, many of which cause fatigue and delirium, which might affect test 
performance and have an impact on the test scores. 
There are important implications of this study. The results suggest that use of beta-
blockers at a level commonly prescribed in a nursing home setting does not appear to 
have a significant impact on memory. This can help practitioners and health care 
providers to decide what type of anti-hypertensive medication are suitable for a patient. If 
possible, a similar study should be replicated. More detailed analysis including placebos 
and measurable doses of beta-blockers should also be conducted in the future.  
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Table 1 
Descriptive statistics of demographic variables 
______________________________________________________________________  
                                            Beta-blocker vs Not taking beta-blockers 
Beta-blocker              Age              Education     Gender 
______________________________________________________________________  
Yes  60.61 (11.71)  13.35 (4.38) 7/236 = 2.97% Female 
      229/236 = 97.03% Male 
No  64.87 (10.92)  12.57 (2.19) 15/233 = 6.44% Female 






EFFECT OF BETA-BLOCKERS ON MEMORY 28 
Table 2 
Descriptive statistics of test scores 
______________________________________________________________________  
                                            Beta-blocker vs Not taking beta-blockers 
Test     Beta-blockers  Not on beta-blockers 
______________________________________________________________________  
MMSE total        26.95 (2.25)  26.99 (2.38)  
MMSE Recall (Ball, Flag and Tree)   2.14 (1.13)  2.30 (0.85) 
HVLT Trails 1 to 3       17.57 (5.38)  18.27 (5.14) 
HVLT Trail 4         5.33 (2.98)  5.59 (3.25) 
HVLT Recognition Trail       10.29 (2.75)  10.32 (1.94) 
__________________________________________________________________ 
Mean (Standard deviation) 
MMSE = Mini Mental Standard Examination 
MMSE Recall = Mini Mental Standard Examination Recall Trials 
HVLT Trails 1 to 3= Hopkins Verbal Learning Test Trails 1 to 3 
HVLT Recognition Trail = Hopkins Verbal Learning Test Recognition Trail 
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Table 3 
Correlation between demographic variables and outcome 
______________________________________________________________________  
Test     Age  Education Beta-blocker (Yes/No) 
______________________________________________________________________  
MMSE total   -0.211*  0.149*  -0.005 
MMSE Recall   -0.182*    0.044       -0.075 
(Ball, Flag and Tree)  
HVLT Trails 1 to 3  0.375*    0.118*       -0.067 
HVLT Trail 4   -0.240*   0.136*       -0.036 
HVLT Recognition Trail -0.335*   0.061*       -0.036 
  __________________________________________________________________ 
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 Table 3 
Parameter estimates for covariates in multiple linear regression model 
______________________________________________________________________  
Test    Intercept Age  Education Beta-blocker  
______________________________________________________________________  
MMSE total  28.34 *    -0.045*  -0.005*  0.243 
MMSE Recall   3.08*  -0.015* 0.011      -0.081 
(Ball, Flag and Tree)  
HVLT Trails 1 to 3 26.38*  -0.173* 0.173*      0.209 
HVLT Trail 4  7.93*    -0.065 * 0.119*      0.140 
HVLT Recognition  11.3*  -0.029 * 0.061      0.145 
Trail  
  __________________________________________________________________ 
Note. * p <0.05 
 
